Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003247 |
---|---|
Receipt number | R000003926 |
Scientific Title | Prospective randomized controlled trial to test efficacy and safety of PEG-IFN alpha-2a/Ribavirin (Copegus) plus Raloxifene hydrochloride for postmenopausal women with chronic hepatitis C.(PCR study) |
Date of disclosure of the study information | 2010/02/26 |
Last modified on | 2015/09/10 17:06:25 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/02/24 10:19:12 | ||
2 | Update | 2010/02/24 11:10:32 | Public title Public title |
|
3 | Update | 2010/03/03 19:18:18 | Organization1 |
|
4 | Update | 2011/09/29 14:28:09 | Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
5 | Update | 2013/02/26 12:33:06 | Last follow-up date |
|
6 | Update | 2013/04/02 15:18:37 | Email |
|
7 | Update | 2013/08/30 11:28:46 | Email |
|
8 | Update | 2013/08/30 11:29:06 | Recruitment status |
|
9 | Update | 2015/09/10 17:06:25 | Recruitment status Results |